| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.26▼ | 5.17▲ | 5.15▲ | 5.03▲ | 4.99▲ |
| MA10 | 5.25▼ | 5.11▲ | 5.12▲ | 5.06▲ | 4.83▲ |
| MA20 | 5.19▲ | 5.09▲ | 5.04▲ | 5.04▲ | 4.02▲ |
| MA50 | 5.11▲ | 4.98▲ | 4.99▲ | 4.82▲ | 2.77▲ |
| MA100 | 5.10▲ | 5.01▲ | 5.04▲ | 3.95▲ | 2.47▲ |
| MA200 | 5.02▲ | 5.04▲ | 4.92▲ | 2.92▲ | 3.54▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.015▲ | 0.025▲ | -0.011▼ | 0.042▲ |
| RSI | 59.985▲ | 65.832▲ | 64.150▲ | 58.142▲ | 72.929▲ |
| STOCH | 83.063▲ | 59.468 | 63.671 | 40.046 | 66.179 |
| WILL %R | -30.435 | -24.561▲ | -19.444▲ | -30.556 | -12.680▲ |
| CCI | 26.524 | 197.937▲ | 194.998▲ | 83.571 | 116.214▲ |
|
Friday, August 28, 2026 01:01 PM
On August 17, OmniAb, Inc. (NASDAQ:OABI) announced a global collaboration and license agreement with Eli Lilly and Company (NYSE:LLY) to discover and develop novel ion channel therapeutics. Leveraging ...
|
|
Friday, August 28, 2026 01:01 PM
On August 17, OmniAb, Inc. (NASDAQ:OABI) announced a global collaboration and license agreement with Eli Lilly and Company (NYSE:LLY) to discover and develop novel ion channel therapeutics. Leveraging ...
|
|
Sunday, June 14, 2026 10:30 PM
The article " OmniAb Q1 Earnings Call Highlights " first appeared on MarketBeat.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/11/26 | 5.105 | 5.31 | 5.03 | 5.23 | 724,912 |
| 18/11/26 | 5.05 | 5.1737 | 5.00 | 5.08 | 1,215,073 |
| 17/11/26 | 4.89 | 5.07 | 4.80 | 5.05 | 1,263,866 |
| 16/11/26 | 4.865 | 4.94 | 4.7301 | 4.89 | 1,234,643 |
| 13/11/26 | 4.95 | 4.99 | 4.85 | 4.91 | 851,713 |
| 12/11/26 | 5.065 | 5.08 | 4.73 | 4.95 | 1,403,267 |
| 11/11/26 | 5.10 | 5.20 | 5.035 | 5.10 | 789,373 |
| 10/11/26 | 5.25 | 5.35 | 4.855 | 5.10 | 1,754,378 |
| 09/11/26 | 5.12 | 5.45 | 5.01 | 5.30 | 2,467,331 |
| 06/11/26 | 4.86 | 5.215 | 4.86 | 5.03 | 1,442,252 |
|
|
||||
|
|
||||
|
|